China pruritus therapeutics market was valued at US$ 1,025.8 million in 2023 and is estimated to surpass the market size of US$ 1,711.1 million by 2032 at a CAGR of 5.58% during the forecast period 2024–2032.
South Korea pruritus therapeutics market was valued at US$ 288.01 million in 2023 and is estimated to surpass the market size of US$ 428.01 million by 2032 at a CAGR of 4.50% during the forecast period 2024–2032.
Taiwan pruritus therapeutics market was valued at US$ 174.67 million in 2023 and is estimated to surpass the market size of US$ 225.53 million by 2032 at a CAGR of 2.88% during the forecast period 2024–2032.
Global scaffold technology market was valued at US$ 1,212.2 million in 2023 and is projected to surpass the market size of US$ 4,714.7 million by 2032 at a CAGR of 16.29% during the forecast period 2024–2032.
Japan pruritus therapeutics market was valued at US$ 582.2 million in 2023 and is estimated to surpass the market size of US$ 1,011.5 million by 2032 at a CAGR of 6.33% during the forecast period 2024–2032.
Asia Pacific Preventive Vaccines Market was valued at US$ 20.9 billion in 2023 and is projected to surpass the market valuation of US$ 63.11 billion by 2032 at a CAGR of 13.07% during the forecast period 2024–2032.
Global Regenerative Medicine Market was valued at US$ 59.68 billion in 2023 and is projected to reach a valuation of US$ 472.95 billion by 2032 at a CAGR of 25.86% during the forecast period 2024–2032.
The Global Circulating Tumor Cells Market was valued at US$ 9.5 billion in 2023 and is projected to surpass the market size of US$ 19.0 billion by 2032 at a CAGR of 8.06% during the forecast period 2024–2032.
Global Liposome Development Service Market was valued at US$ 2,322.9 million in 2023 and is projected to attain a market size of US$ 5,016.0 million by 2032 at a CAGR of 8.93% during the forecast period 2024–2032.